Edwards Expects Up To $190 Million In Transcatheter Valve Sales In 2010

Edwards LifeSciences estimates sales of its Sapien transcatheter aortic heart valve will be in the range of $170 million to $190 million in 2010, the company said during its Dec. 10 investor day at its Irvine, Calif., headquarters